Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic polymorphisms and atorvastatin PK/PD in chronic kidney disease
ChiCTR2000041391Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Shantou University Medical College
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of atorvastatin in chronic kidney disease (CKD) and dyslipidemia (2 arms), sponsored by The First Affiliated Hospital of Shantou University Medical College. Primary endpoints: Atorvastatin blood concentration, Triglycerides and 3 more. Started May 2014; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
chronic kidney disease (CKD)dyslipidemia
Beyond the preview
Go deeper on ChiCTR2000041391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041391.